Approval · Notice of Compliance 17062 · 2015
EFICUR: Notice of Compliance 17062
Issued July 9, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17062
- Date
- July 9, 2015
- Company
- Laboratorios Hipra S.A.Amer, Gerona, Spain
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- EXCENEL RTU
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EFICUR | 02443260 | Marketed |
Medicinal ingredients
- CEFTIOFUR HYDROCHLORIDE 50 MG per ML